JP4742239B2 - ビシクロ［３．１．０］ヘキサン誘導体およびその中間体の製造方法 - Google Patents

ビシクロ［３．１．０］ヘキサン誘導体およびその中間体の製造方法 Download PDF

Info

Publication number
JP4742239B2
JP4742239B2 JP2006538449A JP2006538449A JP4742239B2 JP 4742239 B2 JP4742239 B2 JP 4742239B2 JP 2006538449 A JP2006538449 A JP 2006538449A JP 2006538449 A JP2006538449 A JP 2006538449A JP 4742239 B2 JP4742239 B2 JP 4742239B2
Authority
JP
Japan
Prior art keywords
group
unsubstituted
alkyl group
halogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006538449A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007513070A (ja
JP2007513070A5 (enExample
Inventor
ハートナー，フレデリック・ダブリュー
タン，ルーシー
修祥 安田
直樹 吉川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of JP2007513070A publication Critical patent/JP2007513070A/ja
Publication of JP2007513070A5 publication Critical patent/JP2007513070A5/ja
Application granted granted Critical
Publication of JP4742239B2 publication Critical patent/JP4742239B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/08—Saturated compounds having a carboxyl group bound to a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2006538449A 2003-11-07 2004-11-03 ビシクロ［３．１．０］ヘキサン誘導体およびその中間体の製造方法 Expired - Fee Related JP4742239B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51839103P 2003-11-07 2003-11-07
US60/518,391 2003-11-07
PCT/US2004/036574 WO2005047215A2 (en) 2003-11-07 2004-11-03 Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto

Publications (3)

Publication Number Publication Date
JP2007513070A JP2007513070A (ja) 2007-05-24
JP2007513070A5 JP2007513070A5 (enExample) 2007-12-27
JP4742239B2 true JP4742239B2 (ja) 2011-08-10

Family

ID=34590258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538449A Expired - Fee Related JP4742239B2 (ja) 2003-11-07 2004-11-03 ビシクロ［３．１．０］ヘキサン誘導体およびその中間体の製造方法

Country Status (10)

Country Link
US (1) US7786314B2 (enExample)
EP (1) EP1689727A4 (enExample)
JP (1) JP4742239B2 (enExample)
KR (1) KR101204145B1 (enExample)
CN (2) CN100475800C (enExample)
AU (1) AU2004289652B8 (enExample)
CA (1) CA2544560C (enExample)
RU (1) RU2388747C2 (enExample)
TW (1) TWI347316B (enExample)
WO (1) WO2005047215A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5309680B2 (ja) * 2008-05-09 2013-10-09 大正製薬株式会社 フッ素化エステル化合物の製造方法及びその中間体
WO2009142184A1 (ja) * 2008-05-21 2009-11-26 大正製薬株式会社 酵素を用いたビシクロ［３．１．０］ヘキサン誘導体の製造方法
US8742161B2 (en) * 2009-11-18 2014-06-03 Taisho Pharmaceutical Co., Ltd Process for producing optically active bicyclo [3.1.0] hexane derivative using enzyme
CN112074505B (zh) 2018-03-08 2024-04-05 因赛特公司 作为PI3K-γ抑制剂的氨基吡嗪二醇化合物
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2152925C1 (ru) * 1994-08-12 2000-07-20 Эли Лилли Энд Компани Производные аминобицикло[3.1.0]гексан-2,6-дикарбоновой кислоты и фармацевтическая композиция
US5661184A (en) 1994-08-12 1997-08-26 Eli Lilly And Company Psychiatric agents
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
JP2000072731A (ja) * 1998-08-31 2000-03-07 Taisho Pharmaceut Co Ltd ４−置換−２−アミノビシクロ［３．１．０］ヘキサン−２，６−ジカルボン酸誘導体及び製薬用組成物
JP4194715B2 (ja) * 1998-08-31 2008-12-10 大正製薬株式会社 ６−フルオロビシクロ［３．１．０］ヘキサン誘導体
CN1247527C (zh) * 1998-08-31 2006-03-29 大正制药株式会社 6－氟双环[3.1.0]己烷衍生物
PE20001236A1 (es) 1998-11-13 2000-11-10 Lilly Co Eli Moduladores del receptor de aminoacidos excitadores
US6479674B1 (en) * 1999-03-25 2002-11-12 Taisho Pharmaceutical Co., Ltd. Carboxylic acid derivatives and process for producing same
AU6785501A (en) 2000-06-28 2002-01-08 Taisho Pharmaceutical Co Ltd Intermediate and process for producing fluorinated carboxylic acid derivative from the same
CA2441127A1 (en) * 2001-03-14 2002-09-19 Taisho Pharmaceutical Co., Ltd. Process for producing bicyclocarboxylic acid derivative

Also Published As

Publication number Publication date
EP1689727A2 (en) 2006-08-16
US20070112030A1 (en) 2007-05-17
CA2544560C (en) 2014-01-07
CA2544560A1 (en) 2005-05-26
HK1096971A1 (en) 2007-06-15
RU2006119924A (ru) 2007-12-27
EP1689727A4 (en) 2008-12-31
TW200530178A (en) 2005-09-16
KR101204145B1 (ko) 2012-11-22
WO2005047215A2 (en) 2005-05-26
CN100475800C (zh) 2009-04-08
JP2007513070A (ja) 2007-05-24
CN101654410B (zh) 2013-03-06
CN1898224A (zh) 2007-01-17
AU2004289652B8 (en) 2011-01-20
CN101654410A (zh) 2010-02-24
TWI347316B (en) 2011-08-21
US7786314B2 (en) 2010-08-31
AU2004289652A1 (en) 2005-05-26
KR20060131771A (ko) 2006-12-20
HK1139124A1 (en) 2010-09-10
AU2004289652B2 (en) 2010-09-16
RU2388747C2 (ru) 2010-05-10
WO2005047215A3 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
JP7379567B2 (ja) （２ｒ，６ｒ）－ヒドロキシノルケタミンおよび（２ｓ，６ｓ）－ヒドロキシノルケタミンの結晶形態および合成方法
JP2017160234A (ja) ベラプロストの製造方法
JP4742239B2 (ja) ビシクロ［３．１．０］ヘキサン誘導体およびその中間体の製造方法
AU2018340858B2 (en) Chiral auxiliaries and uses thereof
RU2448957C2 (ru) Фторированные производные катарантина, их получение и применение в качестве прекурсоров димерных алкалоидов vinca
JP5960130B2 (ja) テセタキセルおよび関連化合物ならびに対応する合成中間体の調製
JP7109029B2 (ja) Ｐｇｅ１コアブロック誘導体およびその製造方法
KR102436114B1 (ko) 신규한 이노토디올의 제조방법
KR100680080B1 (ko) 신규 카르복실산 유도체 및 그의 제조 방법
JP7164901B2 (ja) ラタノプロステン・ブノド及びその中間体の製造方法、並びにそれらを含む組成物
MXPA06005039A (en) Processes for preparing bicyclo [3.1.0]hexane derivatives, and intermediates thereto
HK1139124B (en) Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto
HK1096971B (en) Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto
US20130006003A1 (en) New synthones for preparation of 19-nor vitamin d derivatives
JP4591778B2 (ja) α，β，γ−置換シクロペンタノン誘導体の製造法
KR102300311B1 (ko) 타칼시톨의 제조방법 및 그를 위한 중간체
WO2022114138A1 (ja) アミノ酸誘導体の製造方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101102

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110222

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110329

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110411

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140520

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140520

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees